Tuberculosis News and Research

Latest Tuberculosis News and Research

Variations in two genes related to inflammation may be a risk factor for lung cancer

Variations in two genes related to inflammation may be a major risk factor for developing lung cancer, according to a team of scientists from the National Cancer Institute and the University of Texas M. D. Anderson Cancer Center.

4 Jul 2007

TB jetsetter not as dangerous as first thought

It seems the jet setting air traveller with tuberculosis (TB) is not quite as dangerous as first thought. According to a federal health official, American lawyer Andrew Speaker has a less severe form of TB than previously diagnosed.

4 Jul 2007

Scientists create sheets of protein-gold arrays

In groundbreaking research, scientists have demonstrated the ability to strategically attach gold nanoparticles -- particles on the order of billionths of a meter -- to proteins so as to form sheets of protein-gold arrays.

28 Jun 2007

Canada enhances capacity to fight infectious disease

Today representatives of all three levels of government and the Canada Foundation for Innovation turned the sod to launch construction of the International Vaccine Centre (InterVac) at the University of Saskatchewan, a $110.4-million project that will significantly enhance Canada's capacity to fight infectious disease in both animals and humans.

26 Jun 2007

Obesity associated with lower risk of active pulmonary tuberculosis in older population of Hong Kong

Obese or overweight Chinese individuals age 65 and older have a lower risk of developing tuberculosis than those at a normal weight, according to a study in the June 25 issue of Archives of Internal Medicine.

26 Jun 2007

WHO ready to tackle drug resistant TB

According to the World Health Organization (WHO) some forms of tuberculosis (TB) are a threat to the security and stability of global health.

25 Jun 2007

First genome-scale model of microbe that causes tuberculosis

Tuberculosis remains one of the biggest killers in the world today being responsible for nearly ten million cases and one and a half million deaths each year.

23 Jun 2007

New plan to contain extensively drug-resistant TB (XDR-TB)

Hundreds of thousands of cases of drug-resistant tuberculosis (TB) can be prevented and as many as 134 000 lives saved through the implementation of a two-year response plan, published/launched today by the World Health Organization (WHO) and the Stop TB Partnership.

22 Jun 2007

Online tuberculosis textbook

An international team of 40 tuberculosis experts headed by Juan Carlos Palomino (Institute of Tropical Medicine, Antwerp, Belgium), Sylvia Cardoso Leao (Sao Paulo, Brazil) and Viviana Ritacco (Buenos Aires, Argentina) published an online tuberculosis textbook.

20 Jun 2007

Foie gras can speed amyloid development

University of Tennessee Graduate School of Medicine professor and researcher Alan Solomon, M.D., director of the Human Immunology and Cancer/Alzheimer's Disease and Amyloid-Related Disorders Research Program, led a team that discovered a link between foie gras prepared from goose or duck liver and the type of amyloid found in rheumatoid arthritis or tuberculosis.

19 Jun 2007

Acquired DNA key to certain bacterial infection

Researchers announced this week the discovery of a mechanism by which Mycobacterium avium - a bacterium which can result in serious lung infections and is prevalent in emphysema and AIDS patients among others - infects tissue cells or macrophages and thus compromises the body's immunity.

19 Jun 2007

New targets for Leishmaniasis

A comparison of three parasite species that cause Leishmaniasis has identified a small number of genes, many new to biology, that will provide a framework to target the search for new treatments.

19 Jun 2007

Veterans treated in psychiatric wards which "threaten their lives"

A report by the Joint Commission on the Accreditation of Health Care Organizations has found serious flaws in services for veterans at two psychiatric wards in a Seattle hospital.

19 Jun 2007

Enbrel safety data for up to 8 years in patients with juvenile rheumatoid arthritis

Amgen and Wyeth Pharmaceuticals, a division of Wyeth have announced the presentation of additional data that showed that the safety profile of Enbrel, (etanercept) was maintained with long-term use in patients with moderate-to-severe juvenile rheumatoid arthritis (JRA) who completed up to eight years of therapy.

17 Jun 2007